A state memorial service was held for Professor Richard Scolyer, a famous cancer researcher and pathologist. This event took place alongside a wider discussion about how people participate in medical research in Australia.

澳洲為著名癌症研究員兼病理學家 Richard Scolyer 教授舉行了一場國葬。在此活動之際，人們也針對澳洲民眾如何參與醫療研究展開了更廣泛的討論。

The memorial service for Professor Scolyer took place at the Sydney Opera House and was attended by top leaders, including Prime Minister Anthony Albanese. Professor Scolyer, who was once named Australian of the Year, was a world expert on skin cancer but sadly died from a brain tumor at age 59. He left a strong professional legacy, having written over 800 scientific papers and developed new immunotherapy treatments. To honor his work, the government has created the Richard Scolyer Chair in Brain Cancer Research with a grant of $5.9 million.

Scolyer 教授的追思會於悉尼歌劇院舉行，總理 Anthony Albanese 等頂尖領袖均出席。Scolyer 教授曾被命名為「年度澳洲之星」，是皮膚癌的世界級專家，但遺憾地在 59 歲時因腦腫瘤逝世。他留下了深厚的專業遺產，撰寫了 800 多篇科學論文並開發了新的免疫治療方法。為了表彰他的貢獻，政府撥款 590 萬美元，設立了「Richard Scolyer 腦癌研究教授席」。

At the same time, the report examines how medical research works in Australia. About 1,850 new clinical trials start every year, mostly in New South Wales and Victoria. The government has provided $750 million over ten years to study rare diseases. While Australia ranks 14th globally for trial registrations, it is particularly strong in Phase 1 trials because of tax incentives. However, Phase 2 and 3 trials are more difficult to organize because Australia has a smaller population than countries like the US or China.

與此同時，該報告分析了澳洲醫療研究的運作方式。每年約有 1,850 個新的臨床試驗啟動，主要集中在紐南威爾斯州和維多利亞州。政府在十年內提供了 7.5 億美元用於研究罕見疾病。雖然澳洲在全球試驗登記排名第 14 位，但由於稅務優惠，在第一期 (Phase 1) 試驗方面特別強勢。然而，由於澳洲人口少於美國或中國等國家，第二期和第三期試驗較難組織。

These trials are divided into two main types: double-blind studies, which use placebos to test if a drug works, and open-label trials, which are common in cancer research when hiding the treatment is not possible. Most of the funding comes from pharmaceutical companies, although the government and non-profit groups also help. The participation of volunteers is essential; for example, research into glaucoma has successfully moved through all three phases because enough patients joined the studies.

這些試驗分為兩大類：一種是雙盲研究，使用安慰劑來測試藥物是否有效；另一種是開放標籤試驗，這在癌症研究中很常見，因為有時無法隱藏治療方案。大部分資金來自製藥公司，不過政府和非營利團體也提供協助。志願者的參與至關重要；例如，青光眼研究之所以能成功通過全部三期試驗，是因為有足夠的患者加入研究。

The death of Professor Scolyer has led the nation to think more about medical advocacy and why it is so important for people to join clinical trials to improve healthcare.

Scolyer 教授的逝世，促使全國進一步思考醫療倡議，以及為何鼓勵民眾參加臨床試驗對於改善醫療保健如此重要。